ArticleRespiratory research2026
Clinical phenotypes of difficult-to-treat and mild asthma defined by cluster analysis.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCluster modelling has demonstrated asthma heterogeneity across disease severities, but contemporary data integrating difficult-to-treat and mild asthma with systematic assessment of comorbidity-focused treatable traits remain limited.
objectiveTo identify and characterise difficult-to-treat and mild asthma clusters in two UK cohorts: Wessex AsThma CoHort of Difficult Asthma (WATCH-DA) and a mild-asthma cohort from the Epigenetics of Severe Asthma study (EOSA-MA).
methodsSeparate K-means clustering was applied to WATCH-DA (n = 498; 11 variables) and EOSA-MA (n = 67; 12 variables). Post-hoc comparisons evaluated demographic, inflammatory, physiological, comorbidity and patient-reported outcome profiles.
resultsSix difficult-to-treat and two mild asthma clusters were identified respectively, all Type-2 (T2)-predominant. Difficult-to-treat asthma clusters differed by sex, age of asthma-onset, body mass index (BMI) and comorbidities. Two clinically controlled clusters, cluster-1 (Early-onset atopic controlled) and cluster-4 (Late-adult-onset non-atopic controlled), showed distinct comorbidity patterns despite lower overall morbidity. Three severe, exacerbation-prone, adult-onset, female predominant difficult-to-treat clusters (Adult-onset eosinophilic exacerbator [cluster-2], Young-adult-onset high-risk exacerbator [cluster-5], Adult-onset obese multimorbid symptomatic [cluster-6]) varied by blood eosinophil counts (BEC), spirometry, BMI, treatment needs, comorbidities, and quality of life. An Adolescent-onset obese atopic obstructive (cluster-3) showed fewer exacerbations but high BEC with worst spirometry and poor asthma control. In mild asthma, cluster-1 (Early-onset atopic mild) showed worse pathophysiological indices and asthma control than cluster-2 (Adolescent-onset mild) but similarly high comorbidity prevalence.
conclusionCharacterisation of difficult-to-treat and mild asthma clusters reveals diverse associated clinical traits and outcomes across the asthma severity spectrum. Recognition of these clusters and their associated comorbidities should prompt early personalised asthma management to address both airway-centric and comorbid disease aspects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.